Judge upholds dismissal of direct purchaser claims over Lamictal pay-for-delay deal
A New Jersey federal judge on Friday affirmed his previous order dismissing claims by direct purchasers that GlaxoSmithKline and Teva Pharmaceuticals entered into an illegal pay-for-delay agreement over the epilepsy drug...To view the full article, register now.
Already a subscriber? Click here to view full article